Manufacturing a daily pill uses a different process than a weekly injection, which could diversify the supply chain
Pharmacies may need to guide patients toward commercially available semaglutide products
Elecoglipron is an oral small molecule GLP-1 RA (receptor agonist), Vanita Aroda, MD, director of Diabetes Clinical Research at Brigham and Womens Hospital, associate professor of medicine at Harvard Medical School, and lead author of this study, told Medical News Today
Second, although PsO and PsA share overlapping inflammatory pathways, they are characterized by partially distinct immune mechanisms
It might take a minute, but it's a critical step in preserving the peptide's intended structure